Stockreport

Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium [Yahoo! Finance]

Tvardi Therapeutics, Inc.  (TVRD) 
PDF biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases, today ann [Read more]